Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
Di | Lobe Sciences Ltd (2): Lobe Sciences receives U.S. Conjugated Psilocin patent | 2 | Stockwatch | ||
17.10. | Lobe Sciences Ltd (2): Lobe Sciences hires Enclave, Peak for financing | 1 | Stockwatch | ||
02.10. | Lobe Sciences Ltd (2): Lobe Sciences receives U.S. patent for psilocin mucate | 4 | Stockwatch | ||
13.08. | Lobe Sciences Ltd (2): Lobe Sciences directors Young, Phillips resign | 1 | Stockwatch | ||
LOBE SCIENCES Aktie jetzt für 0€ handeln | |||||
04.06. | Lobe Sciences Ltd (2): Lobe Sciences talks uplisting possibilities | 1 | Stockwatch | ||
03.06. | Lobe Sciences Ltd (2): Lobe Sciences appoints Ramjeet as director | 1 | Stockwatch | ||
31.05. | Lobe Sciences Ltd (2): Lobe Sciences appoints Sancilio to board of directors | 1 | Stockwatch | ||
30.05. | Lobe Sciences Ltd (2): Lobe Sciences appoints Jacobson to board of directors | 1 | Stockwatch |
Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
---|---|---|---|---|---|
CORE ONE LABS | 0,079 | 0,00 % | New Core One 3D Printer From Prusa May Be the Answer to Its Bambu Problem | ||
BIONXT SOLUTIONS | 0,161 | -2,73 % | Trendwendesignal - Evotec, BioNxt Solutions, Moderna | "Ohne Investition keine Innovation und ohne Innovation kein Fortschritt" sollte das Motto in allen Wirtschaftszweigen der Welt sein. Ob im Maschinenbau, im Automobilbau, der Elektrotechnik wie auch... ► Artikel lesen | |
AMYRIS | - | - | BioMaP-Consortium Contracts Amyris to Support Domestic Medicines Supply | ||
ATAI LIFE SCIENCES | 1,486 | -1,23 % | Psychedelic drug developer Atai rises as RFK Jr picked for top US health agency role | ||
ENTHEON BIOMEDICAL CORP | 0,080 | -8,05 % | Entheon Biomedical Corp (2): Entheon faces delay re mailing of meeting materials | ||
REVIVE THERAPEUTICS | 0,001 | 0,00 % | Revive Therapeutics Ltd.: Revive Therapeutics Provides Update on Research Study Evaluating Bucillamine for Nerve Agent Exposure and Expansion into Viral Infections | TORONTO, Aug. 28, 2024 (GLOBE NEWSWIRE) -- Revive Therapeutics Ltd. ("Revive" or the "Company") (OTCQB: RVVTF) (CSE: RVV) (FRANKFURT:31R), a specialty life sciences company focused on the research... ► Artikel lesen | |
CYBIN | 10,700 | +0,94 % | Cybin Inc (2): Cybin talks phase 2 efficacy data for CYB003 | ||
SOL GLOBAL INVESTMENTS | 0,179 | 0,00 % | SOL Global Investments Corp.: SOL Global Provides Corporate Update on Solana Focused Investment | Toronto, Ontario--(Newsfile Corp. - November 18, 2024) - SOL Global Investments Corp. (CSE: SOL) (OTC Pink: SOLCF) (FSE: 9SB) ("SOL Global" or "the Company") is pleased to announce that it has purchased... ► Artikel lesen | |
AWAKN LIFE SCIENCES | 0,062 | -13,99 % | Awakn Life Sciences Corp.: Awakn Announces Opening of Four Additional AWKN-001 Phase 3 Trial Sites | Toronto, Ontario--(Newsfile Corp. - October 22, 2024) - Awakn Life Sciences Corp. (CSE: AWKN) (OTCQB: AWKNF) (FSE: 954) ("Awakn" or the "Company"), a clinical-stage biotechnology company developing... ► Artikel lesen | |
RAPID DOSE THERAPEUTICS | - | - | Rapid Dose Therapeutics Corp.: Rapid Dose Announces Closing of Final Tranche of Common Share Private Placement | Burlington, Ontario--(Newsfile Corp. - October 30, 2024) - Rapid Dose Therapeutics Corp. (CSE: DOSE) ("RDT" or the "Company") is pleased to announce that it has closed a second and final tranche of... ► Artikel lesen | |
QIAGEN | 40,200 | +3,50 % | Neue 6,00% Aktienanleihe mit Barriere auf QIAGEN in Zeichnung | München (www.anleihencheck.de) - Die Experten vom Zertifikate-Team der Bank Vontobel Europe AG bieten eine neue Aktienanleihe (ISIN DE000VC7RDU1/ WKN VC7RDU) mit Barriere auf die Aktie von QIAGEN (ISIN... ► Artikel lesen | |
EVOTEC | 9,920 | +0,15 % | KURSEXPLOSION bei Biotech-Aktie! BioNTech, Evotec, Nyxoah | Geht es bei Evotec jetzt doch ganz schnell? Ein Finanzinvestor positioniert sich jedenfalls für eine Übernahme und die Aktie schoss zuletzt kräftig nach oben. Ist damit die Enttäuschung über die Quartalszahlen... ► Artikel lesen | |
RELAY THERAPEUTICS | 4,660 | 0,00 % | Aktie von Relay Therapeutics erreicht 52-Wochen-Tief bei 5,59 US-Dollar | ||
CULLINAN THERAPEUTICS | 12,580 | 0,00 % | Cullinan Therapeutics, Inc.: Cullinan Therapeutics Announces Preclinical Data for CLN-978, a CD19-directed T Cell Engager, to be Presented at ACR Convergence 2024 | Cullinan will present new in vitro preclinical data that provide further strong rationale for broad clinical development of CLN-978 in autoimmune diseases Cullinan will share details of global Phase... ► Artikel lesen | |
GALAPAGOS NV | 24,060 | +0,08 % | GALAPAGOS NV - S-8, Securities to be offered to employees in employee benefit plans |